| Name | Sector |
Revenue
$mlns |
M&A Activity | Last 5 Years | ||
|---|---|---|---|---|---|---|
| Total | Buy | Sell | ||||
|
Ardelyx NASDAQ : ARDX Waltham, Massachusetts, United States website |
Life Science | 124 | - | - | - |
|
|
Akebia NASDAQ : AKBA Cambridge, Massachusetts, United States website |
Life Science | 195 | - | - | - |
|
|
Atea Pharmaceuticals NASDAQ : AVIR Boston, Massachusetts, United States website |
Life Science | 351 | - | - | - |
|
|
Akoya Biosciences
NASDAQ : AKYA Marlborough, Massachusetts, United States website |
Life Science | 97 | 1 | 1 | - |
|
|
Apellis Pharmaceuticals
NASDAQ : APLS Waltham, Massachusetts, United States website |
Life Science | 397 | 1 | 1 | - |
|
|
AquaBounty NASDAQ : AQB Harvard, Massachusetts, United States website |
Life Science | 3 | - | - | - |
|
|
Azenta
NASDAQ : BRKS Chelmsford, Massachusetts, United States website |
Life Science | 514 | 29 | 24 | 5 |
|
|
Agios
NASDAQ : AGIO Cambridge, Massachusetts, United States website |
Life Science | 27 | 1 | - | 1 |
|
|
Aldeyra Therapeutics
NASDAQ : ALDX Lexington, Massachusetts, United States website |
Life Science | - | 1 | 1 | - |
|
|
Alnylam
NASDAQ : ALNY Cambridge, Massachusetts, United States website |
Life Science | 1,828 | 1 | 1 | - |
|
|
Allovir NASDAQ : ALVR Waltham, Massachusetts, United States website |
Life Science | 181 | - | - | - |
|
|
Agenus
NASDAQ : AGEN Lexington, Massachusetts, United States website |
Life Science | 156 | 3 | 3 | - |
|
|
Amylyx
Public Cambridge, Massachusetts, United States website |
Life Science | - | 1 | 1 | - |
|
|
Aprea Therapeutics
NASDAQ : APRE Boston, Massachusetts, United States website |
Life Science | - | 1 | 1 | - |
|
|
Acrivon NASDAQ : ACRV Watertown, Massachusetts, United States website |
Life Science | 67 | - | - | - |
|
|
Generation Bio NASDAQ : GBIO Cambridge, Massachusetts, United States website |
Life Science | 6 | - | - | - |
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.
Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.
Try us for 1 week free today!
No obligation. Cancel anytime.
